Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
Copyright 2024 – Finance News Network
Source: Finance News Network
30 Jul 2024 - Andrew Penkethman - CEO & Managing Director - Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
Read More26 Mar 2020 - Cashwerkz Limited (ASX:CWZ) Executive Chairman John Nantes talks about the company's 1H20 results, new partners to the platform, outlook for the second half and impact of COVID-19.
Read More30 Mar 2020 - XTEK Limited (ASX:XTE) Managing Director Philippe Odouard talks 1H20 results, the company's front-line products for the Australian Defence Force and police forces, US strategy and outlook.
Read More10 Dec 2020 - Lepidico Limited (ASX:LPD) Managing Director Joe Walsh discusses the company's strategic collaboration and technology licence agreement with Cornish Lithium, permitting for its plant in Abu Dhabi, and interest in its critical minerals from the United States International Development Finance Corporation.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More18 Mar 2020 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Youd, talks about the company's 1H20 results, progress with key customer trials and work at the Graphene Engineering & Innovation Centre (GEIC) in Manchester, UK.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More20 Mar 2024 - PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
Read More06 Aug 2024 - Alderan Resources Limited (ASX:AD8) Managing Director Scott Caithness discusses the company's exploration targets and progress.
Read More21 Jun 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses shipping an alpha product to a customer, and the development roadmap for the company.
Read More
